A prediction model based on artificial intelligence techniques for disintegration time and hardness of fast disintegrating tablets in pre-formulation tests
BMC Medical Informatics and Decision Making · 2024
DOI: 10.1186/s12911-024-02485-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMC Medical Informatics and Decision Making, 2024. Verfasst von Mehri Momeni und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Informatics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Artificial Intelligence, Excipients. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mashhad University of Medical Sciences.
Abstract (Originalsprache)
Background
The pharmaceutical industry is continually striving to innovate drug development and formulation processes. Orally disintegrating tablets (ODTs) have gained popularity due to their quick release and patient-friendly characteristics. The choice of excipients in tablet formulations plays a critical role in ensuring product quality, highlighting its importance in tablet creation. The traditional trial-and-error approach to this process is both expensive and time-intensive. To tackle these obstacles, we introduce a fresh approach leveraging machine learning and deep learning methods to automate and enhance pre-formulation drug design.
Methods
We collected a comprehensive dataset of 1983 formulations, including excipient names, quantities, active ingredient details, and various physicochemical attributes. Our study focused on predicting two critical control test parameters: tablet disintegration time and hardness. We compared a range of models like deep learning, artificial neural networks, support vector machines, decision trees, multiple linear regression, and random forests.
Results
A 12-layer deep neural network, as a form of deep learning, surpassed alternative techniques by achieving 73% accuracy for disintegration time and 99% for tablet hardness. This success underscores its efficacy in predicting complex pharmaceutical factors. Such an approach streamlines the drug formulation process, reducing iterations and material consumption.
Conclusions
Our findings highlight the deep learning potential in pharmaceutical formulations, particularly for tablet hardness prediction. Future work should focus on enlarging the dataset to improve model effectiveness and extend its application in pharmaceutical product development and assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Informatics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
- Department of pharmaceutics, school of pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
- Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
- Department of Medical Informatics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Tabeshh@mums.ac.Ir.
Förderung
- Mashhad University of Medical Sciences
Zitieren
APA
Momeni, M., Afkanpour, M., Rakhshani, S., Mehrabian, A., & Tabesh, H. (2024). A prediction model based on artificial intelligence techniques for disintegration time and hardness of fast disintegrating tablets in pre-formulation tests. BMC Medical Informatics and Decision Making. https://doi.org/10.1186/s12911-024-02485-4
Vancouver
Momeni M, Afkanpour M, Rakhshani S, Mehrabian A, Tabesh H. A prediction model based on artificial intelligence techniques for disintegration time and hardness of fast disintegrating tablets in pre-formulation tests. BMC Medical Informatics and Decision Making. 2024. doi:10.1186/s12911-024-02485-4
BibTeX
@article{Momeni2024,
author = {Momeni, Mehri and Afkanpour, Marziyeh and Rakhshani, Saleh and Mehrabian, Amin and Tabesh, Hamed},
title = {A prediction model based on artificial intelligence techniques for disintegration time and hardness of fast disintegrating tablets in pre-formulation tests},
journal = {BMC Medical Informatics and Decision Making},
year = {2024},
doi = {10.1186/s12911-024-02485-4}
}
EUVIMED